CVS Health EBITDA Trend

<div class='logoBackup' style='background:#2A0CD0;color: white;font-size:3em;;'>CVS</div>
CVS -- USA Stock  

Earning Report: February 12, 2020  

Check CVS Health fundamental indicators over time to gain insight into the company future performance. Apply historical fundamental analysis to find patters among financial statement drivers such as Direct Expenses of 124.1 B, Consolidated Income of 1.4 B or Cost of Revenue of 165.4 B, as well as many exotic indicators such as Interest Coverage of 7.2, Long Term Debt to Equity of 0.7931 or Calculated Tax Rate of 87.8. This can be a perfect complement to check CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Continue to analysis of CVS Health Correlation with competitors.

CVS Health EBITDA Marginal Breakdown

Showing smoothed Earnings Before Interest Taxes and Depreciation Amortization EBITDA of CVS Health Corporation with missing and latest data points interpolated. EBITDA is a non-GAAP accounting metric that is widely used when assessing the performance of companies; calculated by adding [DepAmor] back to Earning Before Interest and Taxes EBIT.

14.83 B

          10 Years Trend
 Earnings Before Interest Taxes and Depreciation Amortization EBITDA 

CVS Health Regression Statistics

Arithmetic Mean 9,740,145,833
Geometric Mean 9,476,888,896
Coefficient Of Variation 25.07
Mean Deviation 2,006,020,833
Median 9,899,000,000
Standard Deviation 2,442,017,670
Range 8,085,000,000
R Value 0.49
R Squared 0.24
Significance 0.11
Slope 331,474,650

CVS Health EBITDA Over Time

2018  6,745,000,000 
2019  7,756,750,000 
2020  14,830,000,000 

Other Fundumenentals of CVS Health